Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
This report contains market size and forecasts of Insulin Drug Delivery Devices in global, including the following market information:
- Global Insulin Drug Delivery Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Insulin Drug Delivery Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Insulin Drug Delivery Devices companies in 2021 (%)
The global Insulin Drug Delivery Devices market was valued at 14380 million in 2021 and is projected to reach US$ 19500 million by 2028, at a CAGR of 4.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Syringes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insulin Drug Delivery Devices include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Dance Biopharm, Roche and Tandem Diabetes Care and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insulin Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Drug Delivery Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Drug Delivery Devices Market Segment Percentages, by Type, 2021 (%)
- Syringes
- Insulin Pens
- Jet Injectors
- Insulin Pumps
Global Insulin Drug Delivery Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Drug Delivery Devices Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Homecare
- Others
Global Insulin Drug Delivery Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Drug Delivery Devices Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Insulin Drug Delivery Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Insulin Drug Delivery Devices revenues share in global market, 2021 (%)
- Key companies Insulin Drug Delivery Devices sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Insulin Drug Delivery Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Beta Bionics
- Dance Biopharm
- Roche
- Tandem Diabetes Care
- Animas
